{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-G3RTW76D/7bd7fd64-5ea2-492f-aed5-c169ba90eecc/PDF","dcterms:extent":"246 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-G3RTW76D/612fc08a-f1f3-45f5-ab11-e73190eb93c1/TEXT","dcterms:extent":"0 KB"}],"edm:TimeSpan":{"@rdf:about":"2005-2025","edm:begin":{"@xml:lang":"en","#text":"2005"},"edm:end":{"@xml:lang":"en","#text":"2025"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:doc-G3RTW76D","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/URN:NBN:SI:spr-OTYUOTZX"},{"@xml:lang":"sl","#text":"Šport (Ljubljana)"}],"dcterms:issued":"2020","dc:creator":["Jug, Tadej","Žiberna, Lovro","Žvegelj, Gal"],"dc:format":[{"@xml:lang":"sl","#text":"številka:1/2"},{"@xml:lang":"sl","#text":"letnik:68"},{"@xml:lang":"sl","#text":"str. 204-213"}],"dc:identifier":["ISSN:0353-7455","COBISSID:20833027","URN:URN:NBN:SI:doc-G3RTW76D"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Fakulteta za šport"},"dc:subject":[{"@xml:lang":"en","#text":"adverse effects"},{"@xml:lang":"en","#text":"anabolic androgen steroids"},{"@xml:lang":"sl","#text":"anabolični androgeni steroidi"},{"@xml:lang":"sl","#text":"antidoping"},{"@xml:lang":"en","#text":"anti-doping"},{"@xml:lang":"sl","#text":"doping"},{"@xml:lang":"sl","#text":"neželeni učinki"},{"@xml:lang":"sl","#text":"šport"},{"@xml:lang":"sl","#text":"toksičnost"},{"@xml:lang":"en","#text":"toxicity"}],"dcterms:temporal":{"@rdf:resource":"2005-2025"},"dc:title":{"@xml:lang":"sl","#text":"Neželeni učinki uporabe anaboličnih androgenih steroidov| posledice za zdravje športnikov|"},"dc:description":[{"@xml:lang":"sl","#text":"Anabolic androgenic steroids (AAS) are the most commonly used pharmacological group on the List of Prohibited Substances and Methods among elite athletes. In addition, they are also widely used by recreational athletes, adolescents and other adults. The use of AAS is associated with numerous adverse side effects, which we will address in this review paper by organ systems"},{"@xml:lang":"sl","#text":"Anabolični androgeni steroidi (AAS) so najbolj pogosto uporabljena farmakološka skupina iz Liste prepovedanih snovi in postopkov v namene dopinga pri vrhunskih športnikih, prav tako so zelo razširjeni med rekreativnimi športniki, adolescenti in ostalimi odraslimi. Uporaba AAS je povezana s številnimi neželenimi učinki, ki smo jih v tem preglednem članku predstavili po organskih sistemih"}],"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:doc-G3RTW76D","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:doc-G3RTW76D"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:doc-G3RTW76D/7bd7fd64-5ea2-492f-aed5-c169ba90eecc/PDF"},"edm:rights":{"@rdf:resource":"http://rightsstatements.org/vocab/InC/1.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Univerza v Ljubljani, Fakulteta za šport"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:doc-G3RTW76D/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:doc-G3RTW76D"}}}}